Brief: Sinomab Bioscience Announces Loss For Year Of RMB243.1 Mln
25/03/2024 14:01
March 25 (Reuters) - SinoMab BioScience Ltd 3681.HK :
* LOSS FOR YEAR RMB243.1 MILLION VERSUS RMB284.2 MILLION
* FY REVENUE RMB1.4 MILLION
Further company coverage: 3681.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sinomab Bioscience
See all newsBrief: Sinomab Bioscience Posts HY Loss Of RMB127.4 Million
Brief: Sinomab Bioscience Says Fang Liang Resigns As Executive Director
Brief: Sinomab Bioscience Announces Major Deal For Disposal Of Suzhou Property And Facility For RMB280 MLN
Brief: SinoMab Bioscience Appoints Fang Liang As Executive Director
Brief: Hainan Haiyao Plans To Unload Stake In Sinomab Bioscience